Supreme Court to Hear Privacy Case

Involves Marketing of Pharmaceuticals
Supreme Court to Hear Privacy Case
The U.S. Supreme Court has agreed to hear a healthcare privacy case involving whether Vermont can ban the use of certain prescriber-identifiable data in the marketing of pharmaceuticals.

At issue in the case, Sorrell v. IMS Health Inc., et al (10-779) is "whether a (state) law that restricts access to information in nonpublic prescription drug records and affords prescribers the right to consent before their identifying information in prescription drug records is sold or used in marketing violates the First Amendment," according a blog, sponsored by a law firm, that tracks Supreme Court activity.

A U.S. Court of Appeals ruled in November that the Vermont law was unconstitutional. Drug database firms IMS Health, Verispan (now SDI Health) and Source Healthcare Analytics, as well as the Pharmaceutical Research and Manufacturers of America, filed the suit.


About the Author

Howard Anderson

Howard Anderson

News Editor, ISMG

Anderson is news editor of Information Security Media Group and was founding editor of HealthcareInfoSecurity and DataBreachToday. He has more than 40 years of journalism experience, with a focus on healthcare information technology issues. Before launching HealthcareInfoSecurity, he served as founding editor of Health Data Management magazine, where he worked for 17 years, and he served in leadership roles at several other healthcare magazines and newspapers.




Around the Network

Our website uses cookies. Cookies enable us to provide the best experience possible and help us understand how visitors use our website. By browsing inforisktoday.co.uk, you agree to our use of cookies.